Corrigendum to “Eudragit-coated chitosan-tripterygium glycoside conjugate microspheres alleviate DSS-induced experimental colitis by inhibiting the TLR4/NF-B signaling pathway” [Biomed. Pharmacother. 158 (2023) 114194] - 04/03/26

Guohui Xue ^b, 1

  These authors contributed equally.

, Huifang Xiong ^{a, c, d, e,} 1

  These authors contributed equally.

, Shixiu Wang ^{f, g}, Yingjun Fu ^f, Yong Xie ^{a, c, d, e, ⁎}

^a Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China 

^b Department of Clinical Laboratory, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi Province 332000, China 

^c Gastroenterology Institute of Jiangxi Province, Nanchang, Jiangxi Province 330006, China 

^d Key Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, Jiangxi Province 330006, China 

^e JiangXi Clinical Research Center for Gastroenterology, Nanchang, Jiangxi Province 330006, China 

^f Department of Pharmaceutical Sciences, Nanchang University, Nanchang, Jiangxi Province 330006, China 

^g Department of Pharmacy, The 260th Hospital of Chinese People's Liberation Army, Shijiazhuang, Hebei Province 050041, China 

^⁎ Corresponding author at: Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, China. Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University Nanchang Jiangxi Province 330006 China

Le texte complet de cet article est disponible en PDF.